Navigation Links
Orion Health Signs Trinity Design for Japanese Market
Date:1/6/2009

Orion Health has just signed an agreement, which will see Japan's Trinity Design Corporation Ltd, becoming a reseller and distributor of Orion Health's Rhapsody Integration Engine. Trinity Design has already negotiated its first Rhapsody sale with the Kobe Circulation Clinic, part of the Oji HealthCare Corporation that specializes in providing high quality medical care.

Auckland, NZ (PRWEB) January 6, 2009 -- Orion Health http://www.orionhealth.com has just signed an agreement, which will see Japan's Trinity Design Corporation Ltd, http://www.trinity-design.jp becoming a reseller and distributor of Orion Health's Rhapsody Integration Engine.

Trinity Design is a systems implementation and integration company based in Osaka Japan, specializing in the design and development of hospital software and clinical applications.

Trinity Design has already negotiated its first Rhapsody sale with the Kobe Circulation Clinic, part of the Oji HealthCare Corporation that specializes in providing high quality medical care. The Kobe Circulation Clinic is a new state-of-the-art cardiology clinic, located in Kobe city, which is due to open on January 8, 2009.

Orion Health's Rhapsody Integration Engine http://www.orionhealth.com/rhapsody/ will connect data from Japanese Electronic Medical Record (EMR) systems, Personal Healthcare Record (PHR), modalities (such as MRI, CT, cardiology and echo systems) and a remote imaging diagnosis service centre.

"Rhapsody is now running at the Kobe Circulation Clinic and all the tests have been completed successfully. The customer is very satisfied w
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. SouthEast Alaska Regional Health Consortium Selects Orion Health's Rhapsody Integration Engine for Full-scale Application Integration and Monitoring
2. Orion Health's Dr. Chris Hobson Selected to Speak at World Congress Public Health Conference
3. Indevus Pharmaceuticals Licenses European Rights for VANTAS(R) to Orion Corporation
4. Orion Pharma Selects ChemDiv as A Partner in Drug Discovery Services
5. Orion ICG, LLC Announces Acquisition of Cumberland Therapy Services, Inc.
6. Chronic Care Model helps improve people’s health and care
7. AUDIO from Medialink and Solvay Pharmaceuticals: New Initiative Urges Women to Address Mens Health this New Year
8. ev3 Inc. to Present at the 27th Annual J.P. Morgan Healthcare Conference
9. Warner Chilcott to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference
10. Healthcare Organizations Launch Collaborative Initiative to Test HIPAA Transactions Against Proposed 5010 Standards
11. VA Data Show Home Health Technology Improves Access to Care
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Orion Health Signs Trinity Design for Japanese Market 
Orion Health Signs Trinity Design for Japanese Market
(Date:5/23/2012)... HealthDay Reporter , , TUESDAY, May 22 (HealthDay News) ... the procedure, which involves threading a camera through ... But a new study has found that ... and less time-consuming CT-based colon scan. ... for colon cancer screening. Computed tomography (CT) colonography ...
(Date:5/23/2012)... 2012, SAN FRANCISCO A tiny, resilient metal wire ... offer relief to patients with severe heterogeneous emphysema, a ... areas of the lungs, according to the results of ... and France. The wire, called a lung volume reduction ... to take the place of more invasive procedures used ...
(Date:5/22/2012)... Bend, OR Bend Research Inc., a ... announced the expansion of its existing hot-melt ... an 18mm Leistritz twin-screw mixer/extruder. , ... Research,s existing 27mm Leistritz and 19mm Baker ... and continuous high-shear wet-granulation capabilities. Many projects ...
(Date:5/22/2012)... Ky. (May 17, 2012) The University of Kentucky ... to study a deadly blood and bone marrow disease ... million grant from the Edward P. Evans Foundation, along ... of myelodysplastic syndrome (MDS). , The Evans Foundation grant ... three labs at UK, one at Cincinnati Children,s Hospital, ...
(Date:5/22/2012)... TUESDAY, May 22 (HealthDay News) -- Researchers who say ... precancerous colon lesions recommend people with the blood sugar ... others. "Based on our data, it implies that ... age 40, rather than at age 50," said Dr. ... in St. Louis. However, another expert said more ...
Breaking Medicine News(10 mins):Health News:Patients Prefer More Invasive Form of Colon Scan: Study 2Health News:Patients Prefer More Invasive Form of Colon Scan: Study 3Health News:Tiny implanted coil improves lung function in patients with severe emphysema 2Health News:Tiny implanted coil improves lung function in patients with severe emphysema 3Health News:Markey receives $6.25 million to study deadly blood and bone marrow disease 2Health News:Markey receives $6.25 million to study deadly blood and bone marrow disease 3Health News:Middle-Aged Diabetics May Need Earlier Colon Checks 2Health News:Middle-Aged Diabetics May Need Earlier Colon Checks 3
... may reduce the risk of colon polyps, which can develop ... 34 and 77 years old. The participants underwent endoscopic colon ... 1,400 of the women were diagnosed with adenoma, a type ... participants who reported taking aspirin regularly were 25-percent less likely ...
... the United States have low levels of testosterone. Symptoms ... muscle mass, reduced bone density, depression, and anemia. ... for men with the condition. The therapy may be ... research shows testosterone replacement therapy does not increase a ...
... of radiation exposure to the general population. Although there ... believed exposure during the test is responsible for a ... calculate the risk of cancer from exposure to diagnostic ... Cancer Research in the United Kingdom conducted the study. ...
... shows the reason some adolescents experience depression could be ... to have a smaller hippocampus -- the part of ... ,Researchers sampled nearly 30 adolescents between ages 13 ... major depressive disorder.Magnetic resonance imaging was performed to measure ...
... in the United States, 1 million cases of skin cancer ... // actinic keratoses and more than 7,000 people die yearly. ... cancer from developing in some patients. ,Mary Louise Gramkow ... and mowing -- that sort of thing. [I am] just ...
... that affects the gums and bones supporting the teeth. ... only reveal the general health of patients but may ... Japan studied more than 7,450 men and women. Participants ... including cholesterol and C-reactive protein, which are commonly linked ...
Other Medicine News:
(Date:5/23/2012)... -- According to Cold Chain IQ ... excursions in 6% or more of their temperature ... can not only result in product losses, but ... IQ presents a new report examining temperature excursions ... products and leading strategies that the pharmaceutical industry ...
(Date:5/22/2012)... SmallCapVoice.com, Inc. announced today that ... Inc. (PINKSHEETS: MJNA) is now available. The ... . Recent company activity and ... income of approximately $1.21 million on gross ... ended March 31, 2012.  This represents a ...
(Date:5/22/2012)... -- Prime Therapeutics (Prime), a leading pharmacy benefit manager, ... chief financial officer (CFO). DuCharme will lead Prime,s finance ... growth. "Jim brings deep health plan expertise ... within diverse health plans, including Blue Cross and Blue ... Prime. "Based on his strong belief in pharmacy as ...
Breaking Medicine Technology:New 2012 Cold Chain Report Examines the Extent of Temperature Excursions During the Handling of Temperature-Sensitive Pharmaceutical Shipments 2Medical Marijuana Inc. (MJNA) Corporate Update on Industry Company Services and Future Development. First Audio-Webcast Interview With SmallCapVoice.com in Quarterly Series 2Medical Marijuana Inc. (MJNA) Corporate Update on Industry Company Services and Future Development. First Audio-Webcast Interview With SmallCapVoice.com in Quarterly Series 3Medical Marijuana Inc. (MJNA) Corporate Update on Industry Company Services and Future Development. First Audio-Webcast Interview With SmallCapVoice.com in Quarterly Series 4Weikang Bio Technology Announces Fiscal 2010 Financial Results 18927 1Weikang Bio Technology Announces Fiscal 2010 Financial Results 18927 2Weikang Bio Technology Announces Fiscal 2010 Financial Results 18927 3Weikang Bio Technology Announces Fiscal 2010 Financial Results 18927 4Weikang Bio Technology Announces Fiscal 2010 Financial Results 18927 5Weikang Bio Technology Announces Fiscal 2010 Financial Results 18927 6Weikang Bio Technology Announces Fiscal 2010 Financial Results 18927 7Auxilium Pharmaceuticals Inc and Asahi Kasei Pharma Corporation Enter Agreement to Develop Commercialize and Supply XIAFLEX AE In Japan 15658 1Auxilium Pharmaceuticals Inc and Asahi Kasei Pharma Corporation Enter Agreement to Develop Commercialize and Supply XIAFLEX AE In Japan 15658 2Auxilium Pharmaceuticals Inc and Asahi Kasei Pharma Corporation Enter Agreement to Develop Commercialize and Supply XIAFLEX AE In Japan 15658 3Auxilium Pharmaceuticals Inc and Asahi Kasei Pharma Corporation Enter Agreement to Develop Commercialize and Supply XIAFLEX AE In Japan 15658 4Auxilium Pharmaceuticals Inc and Asahi Kasei Pharma Corporation Enter Agreement to Develop Commercialize and Supply XIAFLEX AE In Japan 15658 5Auxilium Pharmaceuticals Inc and Asahi Kasei Pharma Corporation Enter Agreement to Develop Commercialize and Supply XIAFLEX AE In Japan 15658 6Auxilium Pharmaceuticals Inc and Asahi Kasei Pharma Corporation Enter Agreement to Develop Commercialize and Supply XIAFLEX AE In Japan 15658 7Illinois entomology professor May Berenbaum to receive 2011 Tyler Prize 18362 1Illinois entomology professor May Berenbaum to receive 2011 Tyler Prize 18362 2Illinois entomology professor May Berenbaum to receive 2011 Tyler Prize 18362 3
... Survival, Disease Control and Neurotoxicity Data To Be ... Support Picoplatin as a Neuropathy-Sparing Alternative to Oxaliplatin ... Management Team to Host Analyst and Investor Briefing ... SOUTH SAN FRANCISCO, Calif., May 28 Poniard ...
... additional analyses from the Phase II portion of a ... for the treatment of acute heart failure will be ... of the Heart Failure Association of the European Society ... professor of cardiology at the University of Brescia, Italy, ...
Other Medicine Technology:Poniard Pharmaceuticals Announces Progression-Free Survival Data From Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer 2Poniard Pharmaceuticals Announces Progression-Free Survival Data From Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer 3Poniard Pharmaceuticals Announces Progression-Free Survival Data From Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer 4Poniard Pharmaceuticals Announces Progression-Free Survival Data From Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer 5Poniard Pharmaceuticals Announces Progression-Free Survival Data From Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer 6Results and Additional Analyses From Efficacy and Safety Study of Corthera's Relaxin in Acute Heart Failure to be Presented at Heart Failure Congress 2009 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: